Fig. 7.
Both mAb 3E7 and anti-CD59 enhance RTX-mediated killing of DB cells in serum.
Results (averages ± SD, 5 experiments) are reported for treatment with RTX/NHS plus the indicated additions (as described in the legend to Figure 2). In the absence of RTX, 90% of the cells were alive in serum at both 4 and 48 hours. *P < 10−3; †P < 10−2 compared with RTX alone.
